newsfilter
← Latest News
GlobeNewswire·

Bioxytran Announces Government Interest After Initial BARDA Techwatch Light Meeting

BOSTON, MASSACHUSETTS, Jan. 07, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB:BIXT) (the "Company"), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis,